| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90999 |
Unlisted dialysis procedure, inpatient or outpatient |
51,686 |
3,215 |
$275K |
| 83970 |
|
2,529 |
2,233 |
$273K |
| Q4081 |
Injection, epoetin alfa, 100 units (for esrd on dialysis) |
28,280 |
2,139 |
$269K |
| 82728 |
|
2,216 |
1,960 |
$220K |
| 82108 |
|
523 |
465 |
$129K |
| 83540 |
|
2,166 |
1,908 |
$81K |
| 83550 |
|
1,772 |
1,559 |
$77K |
| A4657 |
Syringe, with or without needle, each |
2,862 |
2,489 |
$54K |
| J0887 |
Injection, epoetin beta, 1 microgram, (for esrd on dialysis) |
897 |
420 |
$36K |
| 82570 |
|
444 |
176 |
$20K |
| J1270 |
Injection, doxercalciferol, 1 mcg |
13,044 |
1,100 |
$16K |
| J1756 |
Injection, iron sucrose, 1 mg |
6,051 |
1,767 |
$15K |
| 85041 |
|
2,684 |
2,404 |
$14K |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
1,515 |
1,103 |
$14K |
| 85048 |
|
2,658 |
2,388 |
$11K |
| 90747 |
|
27 |
25 |
$3K |
| J0604 |
Cinacalcet, oral, 1 mg, (for esrd on dialysis) |
1,860 |
503 |
$3K |
| 90674 |
|
122 |
112 |
$1K |
| 85045 |
|
1,049 |
890 |
$1K |
| 82947 |
|
44 |
44 |
$903.75 |
| G0008 |
Administration of influenza virus vaccine |
118 |
108 |
$737.99 |
| 82746 |
|
60 |
50 |
$690.49 |
| 84540 |
|
98 |
64 |
$76.57 |